rs121908428
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000354181.8(SLC12A6):c.2023C>T(p.Arg675Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000277 in 1,442,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R675R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000354181.8 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A6 | NM_001365088.1 | c.2023C>T | p.Arg675Ter | stop_gained | 16/26 | ENST00000354181.8 | NP_001352017.1 | |
LOC124903461 | XR_007064576.1 | n.816+52G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A6 | ENST00000354181.8 | c.2023C>T | p.Arg675Ter | stop_gained | 16/26 | 1 | NM_001365088.1 | ENSP00000346112 | A1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000277 AC: 4AN: 1442752Hom.: 0 Cov.: 27 AF XY: 0.00000278 AC XY: 2AN XY: 719246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Agenesis of the corpus callosum with peripheral neuropathy Pathogenic:4Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2002 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 22, 2017 | Variant summary: The SLC12A6 c.2023C>T (p.Arg675X) variant results in a premature termination codon, predicted to cause a truncated or absent SLC12A6 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. This variant is absent in 121074 control chromosomes. A publication cites the variant in two homozygous siblings affected witn Andermann Syndrome. In addition, multiple reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 5327). This premature translational stop signal has been observed in individual(s) with agenesis of the corpus callosum with peripheral neuropathy (PMID: 12368912). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg675*) in the SLC12A6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC12A6 are known to be pathogenic (PMID: 12368912, 16606917). - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
SLC12A6-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 22, 2024 | The SLC12A6 c.2023C>T variant is predicted to result in premature protein termination (p.Arg675*). This variant was reported in the homozygous state in an individual with peripheral neuropathy associated with agenesis of the corpus callosum (ACCPN) and also in the heterozygous state in an unaffected sibling, indicating an autosomal recessive inheritance pattern (Howard et al. 2002. PubMed ID: 12368912). This variant has not been reported in gnomAD, indicating this variant is rare. This variant is interpreted as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/5327/). Nonsense variants in SLC12A6 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at